Patient Engagement Solutions Market by Component (Software (Pre-Care, Post-Care)) Therapy (CVD, Diabetes, Obesity, Fitness), Function (Telehealth, ePrescribing, Scheduling, Billing), Delivery, End User (Hospital, Payer, Patient) - Global Forecast to 2031

Market Size
$30.41B
MARKET SIZE, 2026
Projected Market Size
$54.16B
MARKET SIZE, 2031
CAGR
12.2%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, SHARE & GROWTH SNAPSHOT

patient-engagement-solutions-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global patient engagement solutions market is projected to grow from USD 30.41 billion in 2026 to USD 54.16 billion by 2031, at a CAGR of 12.2% during the forecast period. The market was valued at USD 26.75 billion in 2025. The patient engagement solutions market is driven by the growing shift toward patient-centric care, rising adoption of digital health technologies, increasing prevalence of chronic diseases, and the expanding use of mobile apps, portals, and remote monitoring tools to support continuous patient interaction.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 26.75 Billion
    Current Market Size (2026): USD 30.41 Billion
    Forecast Market Size (2031): USD 54.16 Billion
    CAGR (2026–2031): 12.2%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America dominated the global patient engagement solutions market, accounting for 48.5% of the market in 2025.
    Component Leader: Software accounted for the largest market share of 59.3% in 2025.
    Fastest-Growing Delivery Mode: Cloud-based is expected to register the highest CAGR of 13.5% during the forecast period.
    Fastest-Growing Application: Home & remote care is expected to register the highest CAGR during the forecast period.
    Therapeutic Area Leader: Chronic diseases held the largest share of the overall market in 2025.
    Functionality Leader: Patient/client scheduling is expected to dominate the market during the forecast period.
    End User Leader: Providers are estimated to account for the largest market share during the forecast period.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Leading companies include McKesson Corporation, Oracle, and Medhost.
    Emerging companies such as WellStack, Relatient, and Xealth have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.

The patient engagement solutions market is fueled by the rapid digitalization of healthcare, increasing demand for personalized care experiences, and the growing emphasis on improving patient adherence and health literacy. In addition, healthcare organizations are investing heavily in platforms that enhance patient empowerment, streamline appointment and medication management, and support coordinated care.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The patient engagement solutions market is rapidly evolving with the rising adoption of mobile health apps, telehealth, AI-driven personalization, and cloud-based platforms. The growing demand for real-time monitoring, seamless EHR integration, and hybrid care models among hospitals, payers, patients, ambulatory care centers, and home healthcare providers is transforming care delivery, driving a shift toward more digital, accessible, and patient-centered engagement tools.

patient-engagement-solutions-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Implementation of government regulations and initiatives to promote patient-centric care
  • Growing adoption of telehealth & remote care
RESTRAINTS
Impact
Level
  • Inadequate interoperability across healthcare providers
  • Shortage of skilled IT professionals in healthcare industry
OPPORTUNITIES
Impact
Level
  • Expansion of remote & home-based care models
  • Integration with wearables & personalized health tech
CHALLENGES
Impact
Level
  • Low patient adoption and engagement over time
  • Fragmented data & siloed digital tools

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Implementation of government regulations and initiatives to promote patient-centric care

Across the globe, governments are increasingly making it mandatory for patients to access health information, adhere to interoperability standards, and engage in value-based care frameworks that prioritize patient involvement in decision-making. Governments' push for electronic health records, digital communication, transparency, and value-based care is encouraging healthcare providers worldwide to adopt patient engagement solutions. Governments' digital health strategies, coupled with reimbursement, are driving demand for patient engagement solutions that improve communication, shared decision-making, and care continuity, thereby fueling the patient engagement market.

Restraint: Inadequate interoperability across healthcare providers

Even though there has been an increase in the adoption of digital technology, IT infrastructure and data standardization remain hindrances to the smooth flow of data between service providers, payers, and care settings. The existence of legacy systems, software incompatibility, and the absence of integration capabilities are acting as hindrances, which are leading to data silos, thereby impacting the effectiveness of patient engagement technology. The absence of interoperability may cause a negative impact on the patient, and the advantages of patient engagement technology may not be achieved.

Opportunity: Expansion of remote & home-based care models

The emphasis on telehealth, hospital-at-home, and the management of chronic diseases outside the conventional clinical model has generated significant interest in digital engagement platforms. Remote care refers to the use of digital channels for messaging, consultation, and follow-up to continue care services. The emphasis on reducing the length of stay for patients and improving patient experience in healthcare settings has given rise to a high level of opportunities for digital engagement platforms.

Challenge: Low patient adoption and engagement over time

Though initial adoption rates on digital platforms may be high, retaining patient engagement over time can be challenging. Differences in digital literacy, age-related issues, limited access to technology, and a lack of personalized content can hinder continuous patient engagement. Moreover, if digital platforms are not user-friendly, part of routine care, or perceived as beneficial for patient health, patients can become disengaged.

PATIENT ENGAGEMENT SOLUTIONS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Offers digital engagement platforms that support patient outreach, medication adherence programs, and care coordination through integrated communication tools and pharmacy connectivity Enhances patient adherence and satisfaction, improves continuity of care, and reduces medication errors through more personalized and timely interactions
Provides AI-driven patient engagement platforms integrated with EHR and analytics systems, enabling personalized communication, automated reminders, virtual care support, and patient education workflows Improves patient activation and self-management, supports proactive care delivery, strengthens clinical decision-making, and drives operational efficiency across care teams
Delivers patient engagement tools embedded within practice management and EHR systems, supporting appointment scheduling, messaging, chronic care management, and real-time patient insights Increases patient-provider connectivity, enhances chronic disease management, reduces administrative burden, and improves overall clinical performance
Develops multi-channel engagement solutions, including patient portals, mobile apps, telehealth, and automated outreach tools tied to real-time clinical data Boosts patient access and engagement, streamlines workflow automation, reduces no-shows, and strengthens quality measure performance for value-based care
Data-driven, personalized patient outreach using analytics to engage patients across the care journey (pre-visit to post-care) via automated, omnichannel communication Improved patient experience, higher care adherence, reduced no-shows/readmissions, better population health outcomes, and stronger value-based care performance

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The patient engagement solutions market ecosystem consists of key players (Veradigm, Oracle, athenahealth) that offer tools like patient portals, mobile apps, telehealth platforms; startups (xealth, Yosi Health), cloud-service providers (Amazon Web Service, IBM Cloud), support scalable deployment, secure data exchange, and enterprise-wide access across multi-site healthcare networks; and end users (Mayo clinics, The Royal Melbourne Hospital, Cleveland Clinic) that rely on these platforms to improve communication, enhance care coordination, and support continuous patient involvement.

patient-engagement-solutions-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

patient-engagement-solutions-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Patient Engagement Solutions Market, By Component

In 2025, the software segment dominated the patient engagement solutions market, driven by the growing use of digital platforms that improve communication, care coordination, and patient self-management. Some of these solutions include patient engagement platforms, mHealth solutions, telecare platforms, remote monitoring software, and automated communication solutions that facilitate personalized engagement. As healthcare payers adopt value-based care delivery models and focus on digital transformation, software solutions enable instant engagement, patient education, and improved patient compliance. This growth is being fueled by the increasing use of digital platforms that make it easier for patients and providers to stay connected, coordinate care, and support patients in managing their health more confidently.

Patient Engagement Solutions Market, By Delivery Mode

In 2025, the on-premise segment held the largest share of the patient engagement solutions market, driven by healthcare institutions' preference for a higher degree of control over data security, as well as the potential for customized solutions integrated with their current IT infrastructure. Needless to say, many healthcare companies, especially those with access to valuable patient data, continue to favor on-premise solutions to maintain control over data governance. Furthermore, traditional systems of this nature, as well as a reputation for reliability, are also working in support of on-premise usage in spite of a growing adoption of cloud technology.

Patient Engagement Solutions Market, By Application

In 2025, the Care Coordination & Communication segment held the largest share of the patient engagement solutions market, market due to the increasing adoption of digital platforms that enable secure messaging, interoperable data exchange, care team collaboration, and real-time patient–provider communication. These solutions integrate with electronic health records (EHRs), health information exchanges (HIEs), and care management systems to support coordinated care delivery, improve clinical workflow efficiency, and enhance patient outcomes across multiple care settings.

Patient Engagement Solutions Market, By Therapeutic Area

In 2025, the chronic diseases segment held the largest share of the patient engagement solutions market. The increasing demand for care services related to chronic diseases, such as diabetes, cardiovascular diseases, and hypertension, requires ongoing monitoring, adherence tools, and a digital platform for their long-term management. It outpaces acute care and health & wellness, with widespread chronic illness in many adults of developed nations. The integration of digital health, along with value-based initiatives focusing on prevention and sustained engagement of patients, gives the market promising growth scenarios across the decade.

Patient Engagement Solutions Market, By Functionality

In 2025, the patient/client scheduling segment held the largest share of the patient engagement solutions market. This is attributed to the increasing use of technology that has streamlined patient appointments. The use of automated patient scheduling has become crucial for enhancing patient engagement, optimizing no-show rates, improving patient flow, and increasing patient convenience. The role of patient engagement in healthcare has become a key priority for healthcare institutions.

Patient Engagement Solutions Market, By End User

In 2025, the providers segment held the largest share of the patient engagement solutions market. An increasing number of hospitals, clinics, and health systems are integrating web-based solutions to facilitate communication, streamline operations, and drive improved outcomes. Healthcare organizations use engagement platforms for appointment scheduling, telemonitoring, portals, education solutions, and medication reminders, among others, due to an ever-increasing emphasis on leveraging provider-driven innovation in patient engagement solutions that meet performance criteria for improved patient experience and optimized clinical operating efficiency.

REGION

Asia Pacific to be fastest-growing region in patient engagement solutions market during forecast period

Asia Pacific is the fastest-growing region in the patient engagement solutions market due to the rapid digitalization of healthcare infrastructure, the widespread adoption of mobile and internet technology by patients, and the adoption of telehealth strategies by healthcare providers in the region. Countries in the Asia Pacific region are also heavily investing in health care information technology to ensure increased patient access, care coordination, and health care efficiency. The large population base of the countries in the region, as well as the rise of chronic diseases, are also fueling the demand for digital patient engagement solutions.

patient-engagement-solutions-market Region

PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX

In the patient engagement solutions market matrix, McKesson Corporation (Star) leads with a dominant market position due to its strong digital health ecosystem and solutions, such as patient communication platforms, medication adherence programs, and integrated care management tools that enhance coordination among patients, providers, and pharmacies. Oneview Healthcare (Emerging Leader) provides digital care platforms that enhance inpatient experience, streamline clinical workflows, and enable real-time communication between patients and care teams.

patient-engagement-solutions-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

  • McKesson Corporation (US)
  • Veradigm LLC (US)
  • Oracle (US)
  • athenahealth (US)
  • Health Catalyst (US)
  • GetWellNetwork, Inc. (US)
  • Lincata, Inc. (US)
  • Cognizant (US)
  • TruBridge (US)
  • Oneview Healthcare (Ireland)
  • AdvancedMD, Inc. (US)
  • Epic Systems Corporation (US)
  • Harris Healthcare (US)
  • Medical Information Technology, Inc. (US)
  • Tebra Technologies, Inc (US)
  • Televox (US)
  • Microsoft (US) (Nuance Communications, Inc.)
  • Solutionreach, Inc. (US)
  • Experian Information Solutions, Inc. (US)
  • eClinicalWorks (US)

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) (Base Year) USD 26.75 BN
Market Size in 2026 (Value) (Estimated Year) USD 30.41 Billion
Market Forecast in 2031 (Value) (Forecast Year) USD 54.16 BN
CAGR 12.20%
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Component:
    • Hardware
    • Software
    • Services
  • By Delivery Mode:
    • On-Premise
    • Cloud-based/Web-based
  • By Application:
    • Clinical Care
    • Care Coordination & Communication
    • Home & Remote Care
    • Population Health & Behavioral Engagement
    • Financial Engagement
    • Others
  • By Therapeutic Area:
    • Chronic Diseases
    • Women’s Health
    • Fitness
    • Other Therapeutic Areas
  • By Functionality:
    • Patient/Client Scheduling
    • Telehealth
    • E-prescribing
    • Document Management
    • Billing & Payments
    • Patient Education
    • Other Functionality
  • By End User:
    • Providers
    • Payers
    • Patients
    • Other End Users
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa
Related Segment & Geographic Reports Europe Patient Engagement Solutions Market
Asia Pacific Patient Engagement Solutions Market
United States Patient Engagement Solutions Market

WHAT IS IN IT FOR YOU: PATIENT ENGAGEMENT SOLUTIONS MARKET REPORT CONTENT GUIDE

patient-engagement-solutions-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Local Competitive Landscape Profiling of leading patient engagement solution providers (e.g., Oracle, McKesson, Health Catalyst) covering capabilities such as patient portals, mobile apps, remote monitoring, telehealth integration, AI-driven engagement tools, deployment models (cloud/on-premise), and pricing frameworks Enables competitive benchmarking, identifies functional and compliance gaps, and supports vendor selection, partnership evaluation, and market positioning strategies
Regional Market Entry Strategy Assessment of region-wise digital health maturity, smartphone/internet penetration, provider adoption readiness, interoperability requirements with EHRs/PHRs, regulatory considerations (HIPAA, GDPR, PDPA, PIPL), and distribution/channel ecosystem across North America, Europe, Asia Pacific, and emerging markets Reduces market entry barriers, supports localization of digital tools, accelerates compliance readiness, ensures alignment with clinical workflow standards, and helps prioritize high-growth geographies
Local Risk & Opportunity Assessment Evaluation of data-privacy vulnerabilities, patient data consent regulations, cybersecurity demands, digital literacy gaps, reimbursement models for telehealth and remote monitoring, and emerging opportunities in chronic disease management, home-based care, and virtual engagement Strengthens risk mitigation planning, informs investments in secure data governance, identifies high-opportunity use cases (e.g., chronic care, behavioral health), and highlights provider segments with strong adoption potential
Technology Adoption by Region Mapping adoption trends of omnichannel engagement tools, telehealth platforms, AI-driven personalization engines, mobile health apps, remote patient monitoring, and integration maturity with EHR/CRM systems across key countries Informs region-specific product strategy, supports targeted roll-out of advanced analytics and compliance modules, and aligns offerings with digital-transformation and safety-standard requirements

RECENT DEVELOPMENTS

  • January 2025 : Health Catalyst signed an agreement to acquire Upfront Healthcare Services, a patient engagement platform, to expand its engagement capabilities and improve personalized patient outreach and care coordination.
  • September 2025 : Oneview Healthcare partnered with Children’s Hospital of Orange County (CHOC) to implement its MyStay Mobile patient engagement platform, enhancing digital access to education, information, and services for patients and families.
  • June 2024 : Veradigm, Think Healthcare, and Medsien collaborated to integrate remote patient monitoring and care tools using Veradigm’s APIs, enabling real-time data sharing that helps improve patient management, reduce emergency visits, and support proactive care.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
41
2
EXECUTIVE SUMMARY
 
 
 
 
 
47
3
PREMIUM INSIGHTS
 
 
 
 
 
52
4
MARKET OVERVIEW
Telehealth's rise reshapes patient care, yet privacy and interoperability hurdles persist.
 
 
 
 
 
55
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING ADOPTION OF TELEHEALTH AND REMOTE CARE
 
 
 
 
 
 
4.2.1.2
INCREASING SMARTPHONE USE AND DIGITAL COMFORT
 
 
 
 
 
 
4.2.1.3
IMPLEMENTATION OF GOVERNMENT REGULATIONS AND INITIATIVES TO PROMOTE PATIENT-CENTRIC CARE
 
 
 
 
 
 
4.2.1.4
GROWING PREVALENCE OF CHRONIC DISEASES AND RISING DEMAND FOR LONG-TERM PATIENT INVOLVEMENT
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
DATA PRIVACY AND CYBERSECURITY CONCERNS
 
 
 
 
 
 
4.2.2.2
INADEQUATE INTEROPERABILITY ACROSS HEALTHCARE PROVIDERS
 
 
 
 
 
 
4.2.2.3
SHORTAGE OF SKILLED IT PROFESSIONALS IN HEALTHCARE INDUSTRY
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EXPANSION OF REMOTE AND HOME-BASED CARE MODELS
 
 
 
 
 
 
4.2.3.2
AI-DRIVEN PERSONALIZATION IN PATIENT ENGAGEMENT SOLUTIONS
 
 
 
 
 
 
4.2.3.3
INTEGRATION WITH WEARABLES AND PERSONALIZED HEALTH TECH
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
LOW PATIENT ADOPTION AND ENGAGEMENT OVER TIME
 
 
 
 
 
 
4.2.4.2
FRAGMENTED DATA AND SILOED DIGITAL TOOLS
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive pressures and seize opportunities in the evolving global healthcare IT landscape.
 
 
 
 
 
63
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.3
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.4
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMICS OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
ROLE IN ECOSYSTEM
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT, 2025
 
 
 
 
 
 
5.5.2
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2025
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO FOR HS CODE 8528, 2021–2024
 
 
 
 
 
 
5.6.2
IMPORT SCENARIO FOR HS CODE 8471, 2021–2024
 
 
 
 
 
 
5.6.3
EXPORT SCENARIO FOR HS CODE 8528, 2021–2024
 
 
 
 
 
 
5.6.4
EXPORT SCENARIO FOR HS CODE 8471, 2021–2024
 
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP
 
 
 
 
 
 
5.10.2
BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: CHILDREN’S HOSPITAL CASE STUDY
 
 
 
 
 
 
5.10.3
IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF ON PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
 
 
5.11.1
KEY TARIFF RATES
 
 
 
 
 
 
5.11.2
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.3
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.11.3.1
US
 
 
 
 
 
 
5.11.3.2
EUROPE
 
 
 
 
 
 
5.11.3.3
ASIA PACIFIC
 
 
 
 
 
5.11.4
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.11.4.1
HOSPITALS AND HEALTHCARE SYSTEMS
 
 
 
 
 
 
5.11.4.2
ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
 
 
 
 
 
 
5.11.4.3
HOME HEALTHCARE PROVIDERS
 
 
 
 
 
 
5.11.4.4
PRIVATE PAYERS
 
 
 
 
 
 
5.11.4.5
PUBLIC PAYERS
 
 
 
 
 
 
5.11.4.6
OTHER END USERS
 
 
 
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
Harness AI and emerging tech to revolutionize patient engagement and healthcare delivery.
 
 
 
 
 
82
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
CLOUD COMPUTING
 
 
 
 
 
 
6.1.2
API & EHR INTEGRATION TECHNOLOGIES
 
 
 
 
 
 
6.1.3
DATA ANALYTICS
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
 
 
 
 
 
 
6.2.2
CONVERSATIONAL AI/CHATBOTS
 
 
 
 
 
 
6.2.3
BEHAVIORAL ANALYTICS AND PERSONALIZATION ENGINES
 
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
CYBERSECURITY AND DATA ENCRYPTION
 
 
 
 
 
 
6.3.2
BLOCKCHAIN
 
 
 
 
 
 
6.3.3
BIG DATA AND ADVANCED ANALYTICS
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
PATENT PUBLICATION TRENDS FOR PATIENT ENGAGEMENT SOLUTION
 
 
 
 
 
 
6.5.2
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
 
 
 
 
 
 
6.5.3
LIST OF PATENTS/PATENT APPLICATIONS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
 
 
6.6.1
AI-DRIVEN PREDICTIVE ENGAGEMENT
 
 
 
 
 
 
6.6.2
CONTINUOUS REMOTE CARE AND HOSPITAL-AT-HOME ENABLEMENT
 
 
 
 
 
 
6.6.3
PERSONALIZED DIGITAL THERAPEUTICS AND BEHAVIORAL COACHING
 
 
 
 
 
 
6.6.4
CLOSED-LOOP CARE COORDINATION AND VALUE-BASED PERFORMANCE OPTIMIZATION
 
 
 
 
 
 
6.6.5
DECENTRALIZED CLINICAL TRIALS AND REAL-WORLD EVIDENCE GENERATION
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
 
 
6.7.1
INTRODUCTION
 
 
 
 
 
 
6.7.2
MARKET POTENTIAL OF AI/GEN AI IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
6.7.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
 
 
 
 
 
 
 
6.7.3.1
AI-DRIVEN CONVERSATIONAL AI FOR PRE/POST-OP ENGAGEMENT
 
 
 
 
 
6.7.4
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
 
 
 
 
 
 
 
6.7.4.1
PATIENT COMMUNICATION & VIRTUAL CARE PLATFORMS
 
 
 
 
 
 
6.7.4.2
REMOTE PATIENT MONITORING & DIGITAL THERAPEUTICS
 
 
 
 
 
 
6.7.4.3
POPULATION HEALTH & HEALTH EQUITY PROGRAMS
 
 
 
 
 
6.7.5
USER READINESS AND IMPACT ASSESSMENT
 
 
 
 
 
 
 
6.7.5.1
USER READINESS
 
 
 
 
 
 
 
 
6.7.5.1.1
USER A: HOSPITALS & CLINICS
 
 
 
 
 
 
6.7.5.1.2
USER B: HEALTHCARE PROVIDERS, EMPLOYERS, AND FORENSIC AGENCIES
 
 
 
 
6.7.5.2
IMPACT ASSESSMENT
 
 
 
 
 
 
 
 
6.7.5.2.1
USER A: CLINICAL, REFERENCE, AND TOXICOLOGY LABORATORIES
 
 
 
 
 
 
6.7.5.2.2
USER B: HEALTHCARE PROVIDERS, EMPLOYERS, AND FORENSIC AGENCIES
 
7
REGULATORY LANDSCAPE
Navigate complex global regulations with insights into regional compliance and industry standards.
 
 
 
 
 
96
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
REGULATORY FRAMEWORK
 
 
 
 
 
 
 
7.1.2.1
NORTH AMERICA
 
 
 
 
 
 
7.1.2.2
EUROPE
 
 
 
 
 
 
7.1.2.3
ASIA PACIFIC
 
 
 
 
 
 
7.1.2.4
LATIN AMERICA
 
 
 
 
 
 
7.1.2.5
MIDDLE EAST & AFRICA
 
 
 
 
 
7.1.3
INDUSTRY STANDARDS
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Identify key decision influencers and unmet needs shaping buyer behavior in patient engagement solutions.
 
 
 
 
 
105
 
8.1
INTRODUCTION
 
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.5
UNMET NEEDS/END-USER EXPECTATIONS
 
 
 
 
 
 
 
8.5.1
UNMET NEEDS
 
 
 
 
 
 
8.5.2
END-USER EXPECTATIONS
 
 
 
 
 
8.6
MARKET PROFITIBILITY
 
 
 
 
 
9
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 20 Data Tables
 
 
 
 
 
111
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
HARDWARE
 
 
 
 
 
 
 
9.2.1
IN-ROOM TELEVISIONS
 
 
 
 
 
 
 
9.2.1.1
RISING PATIENT DEMAND FOR REAL-TIME HEALTH TRANSPARENCY AND SMART ROOM MODERNIZATION INITIATIVES TO DRIVE MARKET
 
 
 
 
 
9.2.2
INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES
 
 
 
 
 
 
 
9.2.2.1
HOSPITALS TO INCREASINGLY ADOPT BEDSIDE TERMINALS TO ADDRESS WORKFORCE SHORTAGES AND REDUCE NURSING WORKLOAD
 
 
 
 
 
9.2.3
TABLETS
 
 
 
 
 
 
 
9.2.3.1
STRONG ROI PROFILE, LOWER UPFRONT INVESTMENT, AND RAPID ROLLOUT CAPABILITY TO PROPEL MARKET GROWTH
 
 
 
 
9.3
SOFTWARE
 
 
 
 
 
 
 
9.3.1
PRE-CARE ENGAGEMENT
 
 
 
 
 
 
 
9.3.1.1
INCREASING ADOPTION OF CONSUMER-CENTRIC ACCESS MODELS TO AID SEGMENT GROWTH
 
 
 
 
 
9.3.2
POINT-OF-CARE ENGAGEMENT
 
 
 
 
 
 
 
9.3.2.1
EXPONENTIAL GROWTH IN HEALTHCARE DATA AND RISING INFORMATION COMPLEXITY TO AUGMENT SEGMENT GROWTH
 
 
 
 
 
9.3.3
POST-CARE ENGAGEMENT
 
 
 
 
 
 
 
9.3.3.1
SHIFT TOWARD VALUE-BASED CARE AND REIMBURSEMENT MODELS FOR READMISSION RATES TO DRIVE SEGMENT GROWTH
 
 
 
 
9.4
SERVICES
 
 
 
 
 
 
 
9.4.1
IMPLEMENTATION & INTEGRATION SERVICES
 
 
 
 
 
 
 
9.4.1.1
NEED FOR EXPERTISE TO OPERATIONALIZE SOPHISTICATED PATIENT ENGAGEMENT ECOSYSTEMS TO FUEL MARKET GROWTH
 
 
 
 
 
9.4.2
TRAINING & EDUCATION SERVICES
 
 
 
 
 
 
 
9.4.2.1
NEED TO ERADICATE MEASURABLE STAFF USABILITY CHALLENGES AND PATIENT DIGITAL ACCESS GAPS TO DRIVE SEGMENT
 
 
 
 
 
9.4.3
SUPPORT & MAINTENANCE SERVICES
 
 
 
 
 
 
 
9.4.3.1
DEPENDENCY ON PATIENT PORTALS, TELEHEALTH SYSTEMS, AND INTEGRATED EHR INFRASTRUCTURES TO AID MARKET GROWTH
 
 
 
 
 
9.4.4
CONSULTING SERVICES
 
 
 
 
 
 
 
9.4.4.1
SHIFT FROM VOLUME-BASED TO VALUE-BASED CARE MODELS TO DRIVE CONSULTING SERVICES MARKET
 
 
 
10
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables
 
 
 
 
 
126
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
ON-PREMISES
 
 
 
 
 
 
 
10.2.1
ON-PREMISES ADOPTION TO ACCELERATE AMID SECURITY, REGULATORY, AND INTEGRATION PRIORITIES
 
 
 
 
 
10.3
CLOUD-BASED
 
 
 
 
 
 
 
10.3.1
CLOUD-BASED PATIENT ENGAGEMENT TO PROPEL SCALABLE, SECURE, AND INTEROPERABLE CARE
 
 
 
 
11
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 13 Data Tables
 
 
 
 
 
130
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
CLINICAL CARE
 
 
 
 
 
 
 
11.2.1
VALUE-BASED CARE MODELS AND TELEHEALTH EXPANSION TO PROPEL CLINICAL CARE SEGMENT
 
 
 
 
 
11.3
CARE COORDINATION & COMMUNICATION
 
 
 
 
 
 
 
11.3.1
FRAGMENTED CARE PATHWAYS AND INTEROPERABILITY MANDATES TO ACCELERATE MARKET GROWTH
 
 
 
 
 
11.4
HOME & REMOTE CARE
 
 
 
 
 
 
 
11.4.1
HOSPITAL-AT-HOME EXPANSION, READMISSION PENALTIES, AND RPM REIMBURSEMENT TO FUEL SEGMENT GROWTH
 
 
 
 
 
11.5
POPULATION HEALTH & BEHAVIORAL ENGAGEMENT
 
 
 
 
 
 
 
11.5.1
VALUE-BASED CARE MANDATES, RISK STRATIFICATION, AND BEHAVIORAL HEALTH INTEGRATION TO PROPEL SEGMENT GROWTH
 
 
 
 
 
11.6
FINANCIAL ENGAGEMENT
 
 
 
 
 
 
 
11.6.1
RISING OUT-OF-POCKET COSTS, CONSUMERISM, AND REVENUE PRESSURE TO DRIVE FINANCIAL ENGAGEMENT ADOPTION
 
 
 
 
 
11.7
OTHER APPLICATIONS
 
 
 
 
 
12
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 16 Data Tables
 
 
 
 
 
139
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
CHRONIC DISEASES
 
 
 
 
 
 
 
12.2.1
CARDIOVASCULAR DISEASES
 
 
 
 
 
 
 
12.2.1.1
NEED FOR CONTINUOUS MONITORING AND PREVENTIVE ENGAGEMENT THROUGH DIGITAL HEALTH PLATFORMS TO DRIVE MARKET
 
 
 
 
 
12.2.2
DIABETES
 
 
 
 
 
 
 
12.2.2.1
CONTINUOUS GLUCOSE MONITORING, BEHAVIORAL ADHERENCE, AND DATA-DRIVEN SELF-MANAGEMENT THROUGH DIGITAL ENGAGEMENT TO DRIVE MARKET
 
 
 
 
 
12.2.3
OBESITY
 
 
 
 
 
 
 
12.2.3.1
PREVENTIVE ENGAGEMENT, BEHAVIORAL MODIFICATION, AND LONG-TERM RISK REDUCTION THROUGH DIGITAL HEALTH PLATFORMS TO DRIVE MARKET
 
 
 
 
 
12.2.4
RESPIRATORY DISORDERS
 
 
 
 
 
 
 
12.2.4.1
ADVANCING CONTINUOUS SYMPTOM MONITORING AND PREVENTIVE CARE THROUGH DIGITAL ENGAGEMENT PLATFORMS TO FUEL MARKET GROWTH
 
 
 
 
 
12.2.5
ONCOLOGY
 
 
 
 
 
 
 
12.2.5.1
LONGITUDINAL CARE COORDINATION, SYMPTOM MONITORING, AND SURVIVORSHIP ENGAGEMENT TO BOOST MARKET
 
 
 
 
 
12.2.6
OTHER CHRONIC DISEASES
 
 
 
 
 
12.3
WOMEN'S HEALTH
 
 
 
 
 
 
 
12.3.1
PREVENTIVE SCREENING, REPRODUCTIVE CARE COORDINATION, AND LIFECYCLE ENGAGEMENT TO AID MARKET GROWTH
 
 
 
 
 
12.4
BEHAVIORAL & MENTAL HEALTH
 
 
 
 
 
 
 
12.4.1
INCREASING GLOBAL PREVALENCE OF DEPRESSION, ANXIETY, SUBSTANCE USE DISORDERS TO AID MARKET GROWTH
 
 
 
 
 
12.5
OTHER THERAPEUTIC AREAS
 
 
 
 
 
13
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
151
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
PATIENT/CLIENT SCHEDULING
 
 
 
 
 
 
 
13.2.1
DIGITAL-FIRST, MOBILE-DRIVEN SCHEDULING TO REDUCE NO-SHOWS AND STRENGTHEN ACCESS PERFORMANCE
 
 
 
 
 
13.3
TELEHEALTH
 
 
 
 
 
 
 
13.3.1
TELEHEALTH TO DRIVE QUALITY IMPROVEMENT AND HYBRID CARE DELIVERY GROWTH
 
 
 
 
 
13.4
E-PRESCRIBING
 
 
 
 
 
 
 
13.4.1
E-PRESCRIBING TO STRENGTHEN MEDICATION SAFETY REGULATORY COMPLIANCE
 
 
 
 
 
13.5
DOCUMENT MANAGEMENT
 
 
 
 
 
 
 
13.5.1
DIGITAL RECORD ACCESS TO DRIVE DOCUMENT MANAGEMENT IN CORE PATIENT ENGAGEMENT INFRASTRUCTURE
 
 
 
 
 
13.6
BILLING & PAYMENTS
 
 
 
 
 
 
 
13.6.1
RISING PATIENT FINANCIAL RESPONSIBILITY AND GROWING DEMAND FOR DIGITAL TRANSPARENCY TO DRIVE MARKET
 
 
 
 
 
13.7
PATIENT EDUCATION
 
 
 
 
 
 
 
13.7.1
SELF-DIRECTED HEALTH RESEARCH AND DIGITAL LITERACY GAPS TO RISE DEMAND FOR INTEGRATED PATIENT EDUCATION TOOLS
 
 
 
 
 
13.8
OTHER FUNCTIONALITIES
 
 
 
 
 
14
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables
 
 
 
 
 
160
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
PROVIDERS
 
 
 
 
 
 
 
14.2.1
HOSPITALS & HEALTHCARE SYSTEMS
 
 
 
 
 
 
 
14.2.1.1
HEALTHCARE SYSTEMS TO DRIVE PATIENT EXPERIENCE AND OPERATIONAL EFFICIENCY THROUGH INTEGRATED PATIENT ENGAGEMENT SOLUTIONS
 
 
 
 
 
14.2.2
ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
 
 
 
 
 
 
 
14.2.2.1
NEED FOR OPTIMIZING PATIENT ACCESS AND ENGAGEMENT IN OUTPATIENT CARE SETTINGS TO PROPEL SEGMENT GROWTH
 
 
 
 
 
14.2.3
HOME HEALTHCARE PROVIDERS
 
 
 
 
 
 
 
14.2.3.1
HOME HEALTHCARE PROVIDES TO ENHANCE PATIENT ENGAGEMENT AND REMOTE CARE DELIVERY IN HOME SETTINGS
 
 
 
 
 
14.2.4
OTHER PROVIDERS
 
 
 
 
 
14.3
PAYERS
 
 
 
 
 
 
 
14.3.1
PRIVATE PAYERS
 
 
 
 
 
 
 
14.3.1.1
PRIVATE PAYERS TO ENHANCE MEMBER EXPERIENCE AND COST EFFICIENCY THROUGH DIGITAL-FIRST ENGAGEMENT STRATEGIES
 
 
 
 
 
14.3.2
PUBLIC PAYERS
 
 
 
 
 
 
 
14.3.2.1
PUBLIC PAYERS TO STRENGTHEN POPULATION HEALTH MANAGEMENT THROUGH INCLUSIVE AND SCALABLE DIGITAL ENGAGEMENT
 
 
 
 
14.4
OTHER END USERS
 
 
 
 
 
15
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 348 Data Tables.
 
 
 
 
 
169
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
 
 
15.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
 
 
15.2.2
US
 
 
 
 
 
 
 
15.2.2.1
VALUE-BASED CARE REFORMS AND LONG-TERM CARE MANAGEMENT NEED TO ACCELERATE MARKET GROWTH
 
 
 
 
 
15.2.3
CANADA
 
 
 
 
 
 
 
15.2.3.1
GOVERNMENT POLICIES TO STRENGTHEN DIGITAL HEALTH INFRASTRUCTURE AND INTEROPERABILITY
 
 
 
 
15.3
EUROPE
 
 
 
 
 
 
 
15.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
 
 
15.3.2
GERMANY
 
 
 
 
 
 
 
15.3.2.1
NATIONWIDE EPA ROLLOUT AND DIGITAL THERAPEUTICS LEADERSHIP TO PROPEL MARKET GROWTH
 
 
 
 
 
15.3.3
FRANCE
 
 
 
 
 
 
 
15.3.3.1
NEAR-UNIVERSAL DIGITAL HEALTH RECORD ADOPTION AND STRATEGIC INVESTMENT TO AID MARKET GROWTH
 
 
 
 
 
15.3.4
UK
 
 
 
 
 
 
 
15.3.4.1
NHS APP SCALE-UP AND VIRTUAL CARE EXPANSION TO BOOST MARKET GROWTH
 
 
 
 
 
15.3.5
ITALY
 
 
 
 
 
 
 
15.3.5.1
RISING DIGITAL HEALTH INVESTMENT AND GROWING FOCUS ON NATIONAL TELEMEDICINE INFRASTRUCTURE TO FUEL MARKET GROWTH
 
 
 
 
 
15.3.6
SPAIN
 
 
 
 
 
 
 
15.3.6.1
RISING TELEMEDICINE EXPANSION AND GROWING MHEALTH ADOPTION TO STRENGTHEN MARKET
 
 
 
 
 
15.3.7
REST OF EUROPE
 
 
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
 
 
15.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
 
 
15.4.2
CHINA
 
 
 
 
 
 
 
15.4.2.1
HIGH DIGITAL HEALTH ADOPTION AND INTERNET HOSPITAL EXPANSION TO ACCELERATE MARKET GROWTH
 
 
 
 
 
15.4.3
JAPAN
 
 
 
 
 
 
 
15.4.3.1
HEALTHCARE DIGITALIZATION TO ACCELERATE PATIENT ENGAGEMENT IN JAPAN
 
 
 
 
 
15.4.4
INDIA
 
 
 
 
 
 
 
15.4.4.1
DIGITAL PUBLIC HEALTH INFRASTRUCTURE AND MOBILE PENETRATION TO AUGMENT MARKET GROWTH
 
 
 
 
 
15.4.5
SOUTH KOREA
 
 
 
 
 
 
 
15.4.5.1
NATIONAL DIGITAL INTEGRATION AND RAPID POPULATION AGING TO AID MARKET GROWTH
 
 
 
 
 
15.4.6
AUSTRALIA
 
 
 
 
 
 
 
15.4.6.1
NEAR-UNIVERSAL DIGITAL RECORDS AND EMBEDDED TELEHEALTH ADOPTION TO FUEL MARKET GROWTH
 
 
 
 
 
15.4.7
REST OF ASIA PACIFIC
 
 
 
 
 
15.5
LATIN AMERICA
 
 
 
 
 
 
 
15.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
 
 
15.5.2
BRAZIL
 
 
 
 
 
 
 
15.5.2.1
GOVERNMENT-LED TELEHEALTH SCALE AND INSTITUTIONALIZED PATIENT PARTICIPATION TO PROPEL DIGITAL ENGAGEMENT
 
 
 
 
 
15.5.3
MEXICO
 
 
 
 
 
 
 
15.5.3.1
STRUCTURAL HEALTH SYSTEM GAPS TO SPUR DIGITAL PATIENT ENGAGEMENT ADOPTION
 
 
 
 
 
15.5.4
REST OF LATIN AMERICA
 
 
 
 
 
15.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
15.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
 
 
15.6.2
GCC COUNTRIES
 
 
 
 
 
 
 
15.6.2.1
HIGH NCD BURDEN AND GOVERNMENT-OWNED DIGITAL PLATFORMS TO AUGMENT PATIENT ENGAGEMENT
 
 
 
 
 
 
15.6.2.2
KINGDOM OF SAUDI ARABIA
 
 
 
 
 
 
 
 
15.6.2.2.1
GOVERNMENT-LED DIGITAL HEALTH INNOVATIONS TO ACCELERATE PATIENT ENGAGEMENT
 
 
 
 
15.6.2.3
UAE
 
 
 
 
 
 
 
 
15.6.2.3.1
PROGRESSIVE DIGITAL HEALTH INNOVATIONS TO STRENGTHEN UAE PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
15.6.2.4
REST OF GCC COUNTRIES
 
 
 
 
 
15.6.3
SOUTH AFRICA
 
 
 
 
 
 
 
15.6.3.1
MASSIVE TELEMEDICINE ADOPTION AND INNOVATIVE DIGITAL PLATFORMS TO AID MARKET GROWTH
 
 
 
 
 
15.6.4
REST OF MIDDLE EAST & AFRICA
 
 
 
 
16
COMPETITIVE LANDSCAPE
Discover how top players dominate patient engagement with strategic innovations and market leadership.
 
 
 
 
 
320
 
16.1
INTRODUCTION
 
 
 
 
 
 
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
16.2.1
OVERVIEW OF KEY STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
16.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
 
16.5
BRAND COMPARISON
 
 
 
 
 
 
 
16.6
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
16.6.1
FINANCIAL METRICS
 
 
 
 
 
 
16.6.2
COMPANY VALUATION
 
 
 
 
 
16.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
16.7.1
STARS
 
 
 
 
 
 
16.7.2
EMERGING LEADERS
 
 
 
 
 
 
16.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
16.7.4
PARTICIPANTS
 
 
 
 
 
 
16.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
16.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
16.7.5.2
REGION FOOTPRINT
 
 
 
 
 
 
16.7.5.3
COMPONENT FOOTPRINT
 
 
 
 
 
 
16.7.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
16.7.5.5
END-USER FOOTPRINT
 
 
 
 
16.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
16.8.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
16.8.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
16.8.3
DYNAMIC COMPANIES
 
 
 
 
 
 
16.8.4
STARTING BLOCKS
 
 
 
 
 
 
16.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
16.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
16.8.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
16.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
16.9.1
PRODUCT LAUNCHES & ENHANCEMENTS
 
 
 
 
 
 
16.9.2
DEALS
 
 
 
 
 
 
16.9.3
EXPANSIONS
 
 
 
 
 
 
16.9.4
OTHER DEVELOPMENTS
 
 
 
 
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
339
 
17.1
KEY PLAYERS
 
 
 
 
 
 
 
17.1.1
MCKESSON CORPORATION
 
 
 
 
 
 
 
17.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
17.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
17.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
17.1.1.3.1
DEALS
 
 
 
 
17.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
17.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
17.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
17.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
17.1.2
ORACLE
 
 
 
 
 
 
17.1.3
MICROSOFT (NUANCE COMMUNICATIONS, INC.)
 
 
 
 
 
 
17.1.4
TRUBRIDGE
 
 
 
 
 
 
17.1.5
HEALTH CATALYST
 
 
 
 
 
 
17.1.6
VERADIGM LLC
 
 
 
 
 
 
17.1.7
ATHENAHEALTH
 
 
 
 
 
 
17.1.8
GETWELLNETWORK, INC.
 
 
 
 
 
 
17.1.9
LINCATA, INC.
 
 
 
 
 
 
17.1.10
COGNIZANT
 
 
 
 
 
 
17.1.11
ONEVIEW HEALTHCARE
 
 
 
 
 
 
17.1.12
ADVANCEDMD, INC.
 
 
 
 
 
 
17.1.13
EPIC SYSTEMS CORPORATION
 
 
 
 
 
 
17.1.14
HARRIS HEALTHCARE
 
 
 
 
 
 
17.1.15
MEDICAL INFORMATION TECHNOLOGY, INC.
 
 
 
 
 
 
17.1.16
TEBRA TECHNOLOGIES, INC.
 
 
 
 
 
 
17.1.17
TELEVOX
 
 
 
 
 
 
17.1.18
SOLUTIONREACH, INC.
 
 
 
 
 
 
17.1.19
EXPERIAN INFORMATION SOLUTIONS, INC.
 
 
 
 
 
 
17.1.20
ECLINICALWORKS
 
 
 
 
 
17.2
OTHER PLAYERS
 
 
 
 
 
 
 
17.2.1
WELLSTACK
 
 
 
 
 
 
17.2.2
RELATIENT
 
 
 
 
 
 
17.2.3
LUMA HEALTH INC.
 
 
 
 
 
 
17.2.4
CIPHERHEALTH INC.
 
 
 
 
 
 
17.2.5
YOSI HEALTH
 
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
403
 
18.1
RESEARCH APPROACH
 
 
 
 
 
 
 
18.1.1
SECONDARY RESEARCH
 
 
 
 
 
 
 
18.1.1.1
KEY SECONDARY SOURCES
 
 
 
 
 
 
18.1.1.2
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
18.1.2
PRIMARY RESEARCH
 
 
 
 
 
 
 
18.1.2.1
PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
 
 
 
 
 
 
18.1.2.3
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.4
BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
18.1.2.5
INSIGHTS FROM PRIMARY EXPERTS
 
 
 
 
18.2
RESEARCH METHODOLOGY DESIGN
 
 
 
 
 
 
18.3
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
18.3.1
BOTTOM-UP APPROACH (REVENUE SHARE ANALYSIS)
 
 
 
 
 
 
18.3.2
TOP-DOWN OF PARENT MARKET ASSESSMENT
 
 
 
 
 
 
18.3.3
PRIMARY INTERVIEWS
 
 
 
 
 
 
18.3.4
TOP-DOWN APPROACH
 
 
 
 
 
18.4
DATA TRIANGULATION
 
 
 
 
 
 
18.5
MARKET SHARE ESTIMATION
 
 
 
 
 
 
18.6
STUDY ASSUMPTIONS
 
 
 
 
 
 
18.7
RESEARCH LIMITATIONS
 
 
 
 
 
 
18.8
RISK ANALYSIS
 
 
 
 
 
19
APPENDIX
 
 
 
 
 
418
 
19.1
DISCUSSION GUIDE
 
 
 
 
 
 
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
19.4
RELATED REPORTS
 
 
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
 
 
 
 
 
 
TABLE 3
IMPACT OF PORTER’S FIVE FORCES ON PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
TABLE 4
ROLE OF COMPANIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET ECOSYSTEM
 
 
 
 
 
 
 
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT,
 
 
 
 
 
 
2025
(USD)
 
 
 
 
 
69
 
INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION,
 
 
 
 
 
 
2025
(USD)
 
 
 
 
 
70
TABLE 7
IMPORT SCENARIO FOR HS CODE 8528, 2021–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 8
IMPORT SCENARIO FOR HS CODE 8741, 2021–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 9
EXPORT SCENARIO FOR HS CODE 8528, 2021–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
EXPORT SCENARIO FOR HS CODE 8471, 2021–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 11
LIST OF KEY CONFERENCES AND EVENTS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, JANUARY 2026–DECEMBER 2027
 
 
 
 
 
 
TABLE 12
CASE STUDY 1: ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP
 
 
 
 
 
 
TABLE 13
CASE STUDY 2: BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: A CHILDREN’S HOSPITAL CASE STUDY
 
 
 
 
 
 
TABLE 14
CASE STUDY 3: IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT
 
 
 
 
 
 
TABLE 15
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 16
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
TABLE 17
LIST OF PATENTS/PATENT APPLICATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
TABLE 18
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 19
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 20
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 22
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 23
REGULATORY SCENARIO OF NORTH AMERICA
 
 
 
 
 
 
TABLE 24
REGULATORY SCENARIO OF EUROPE
 
 
 
 
 
 
TABLE 25
REGULATORY SCENARIO OF ASIA PACIFIC
 
 
 
 
 
 
TABLE 26
REGULATORY SCENARIO OF LATIN AMERICA
 
 
 
 
 
 
TABLE 27
REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
 
 
 
 
 
 
TABLE 28
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF MAJOR END USERS (%)
 
 
 
 
 
 
TABLE 29
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
TABLE 30
UNMET NEEDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
TABLE 31
END-USER EXPECTATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
TABLE 32
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT HARDWARE MARKET
 
 
 
 
 
 
TABLE 34
PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
PATIENT ENGAGEMENT HARDWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
PATIENT ENGAGEMENT HARDWARE MARKET FOR IN-ROOM TELEVISIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
PATIENT ENGAGEMENT HARDWARE MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
PATIENT ENGAGEMENT HARDWARE MARKET FOR TABLETS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOFTWARE MARKET
 
 
 
 
 
 
TABLE 40
PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
PATIENT ENGAGEMENT SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
PATIENT ENGAGEMENT SOFTWARE MARKET FOR PRE-CARE ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
PATIENT ENGAGEMENT SOFTWARE MARKET FOR POINT-OF-CARE ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
PATIENT ENGAGEMENT SOFTWARE MARKET FOR POST-CARE ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SERVICES MARKET
 
 
 
 
 
 
TABLE 46
PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
PATIENT ENGAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
PATIENT ENGAGEMENT SERVICES MARKET FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
PATIENT ENGAGEMENT SERVICES MARKET FOR TRAINING & EDUCATION SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
PATIENT ENGAGEMENT SERVICES MARKET FOR SUPPORT & MAINTENANCE SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
PATIENT ENGAGEMENT SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
KEY COMPANIES OFFERING ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS
 
 
 
 
 
 
TABLE 54
ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
KEY COMPANIES OFFERING CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS
 
 
 
 
 
 
TABLE 56
CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CLINICAL CARE
 
 
 
 
 
 
TABLE 59
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICAL CARE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CARE COORDINATION & COMMUNICATION
 
 
 
 
 
 
TABLE 61
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARE COORDINATION & COMMUNICATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR HOME & REMOTE CARE
 
 
 
 
 
 
TABLE 63
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME & REMOTE CARE, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT
 
 
 
 
 
 
TABLE 65
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR FINANCIAL ENGAGEMENT
 
 
 
 
 
 
TABLE 67
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL ENGAGEMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER APPLICATIONS
 
 
 
 
 
 
TABLE 69
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CHRONIC DISEASES
 
 
 
 
 
 
TABLE 72
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ONCOLOGY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR WOMEN’S HEALTH
 
 
 
 
 
 
TABLE 81
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BEHAVIORAL & MENTAL HEALTH
 
 
 
 
 
 
TABLE 83
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BEHAVIORAL & MENTAL HEALTH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER THERAPEUTIC AREAS
 
 
 
 
 
 
TABLE 85
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT/CLIENT SCHEDULING
 
 
 
 
 
 
TABLE 88
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR TELEHEALTH
 
 
 
 
 
 
TABLE 90
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR E-PRESCRIBING
 
 
 
 
 
 
TABLE 92
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR DOCUMENT MANAGEMENT
 
 
 
 
 
 
TABLE 94
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BILLING & PAYMENTS
 
 
 
 
 
 
TABLE 96
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT EDUCATION
 
 
 
 
 
 
TABLE 98
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER FUNCTIONALITIES
 
 
 
 
 
 
TABLE 100
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS
 
 
 
 
 
 
TABLE 103
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS
 
 
 
 
 
 
TABLE 110
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO OTHER END USERS
 
 
 
 
 
 
TABLE 115
PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
NORTH AMERICA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 118
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
NORTH AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
NORTH AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
NORTH AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
US: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
US: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
US: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
CANADA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
CANADA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
CANADA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
EUROPE: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 156
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
GERMANY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
GERMANY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
GERMANY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
FRANCE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
FRANCE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
FRANCE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
UK: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
UK: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
UK: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
ITALY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
ITALY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
ITALY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
SPAIN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
SPAIN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
SPAIN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
REST OF EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
REST OF EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
REST OF EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
ASIA PACIFIC: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 242
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
CHINA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
CHINA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
CHINA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
JAPAN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
JAPAN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
JAPAN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
INDIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
INDIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
INDIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
SOUTH KOREA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
SOUTH KOREA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
SOUTH KOREA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
AUSTRALIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
AUSTRALIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
AUSTRALIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
LATIN AMERICA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 328
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
LATIN AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
LATIN AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
LATIN AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
BRAZIL: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
BRAZIL: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
BRAZIL: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
MEXICO: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
MEXICO: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
MEXICO: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
REST OF LATIN AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 373
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 374
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 375
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 376
REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 377
MIDDLE EAST & AFRICA: KEY MACROINDICATORS
 
 
 
 
 
 
TABLE 378
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 379
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 380
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 381
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 382
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 383
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 384
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 385
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 386
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 387
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 388
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 389
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 390
MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 391
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 392
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 393
GCC COUNTRIES: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 394
GCC COUNTRIES: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 395
GCC COUNTRIES: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 396
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 397
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 398
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 399
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 400
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 401
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 402
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 403
GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 404
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 405
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 406
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 407
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 408
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 409
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 410
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 411
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 412
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 413
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 414
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 415
KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 416
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 417
UAE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 418
UAE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 419
UAE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 420
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 421
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 422
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 423
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 424
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 425
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 426
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 427
UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 428
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 429
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 430
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 431
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 432
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 433
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 434
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 435
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 436
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 437
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 438
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 439
REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 440
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 441
SOUTH AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 442
SOUTH AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 443
SOUTH AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 444
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 445
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 446
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 447
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 448
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 449
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 450
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 451
SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 452
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 453
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 454
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 455
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 456
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 457
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 458
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 459
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 460
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 461
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 462
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 463
REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 464
OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 465
PATIENT ENGAGEMENT SOLUTIONS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 466
PATIENT ENGAGEMENT SOLUTIONS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 467
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPONENT FOOTPRINT
 
 
 
 
 
 
TABLE 468
PATIENT ENGAGEMENT SOLUTIONS MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 469
PATIENT ENGAGEMENT SOLUTIONS MARKET: END-USER FOOTPRINT
 
 
 
 
 
 
TABLE 470
PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 471
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS/STARTUP PLAYERS, BY REGION
 
 
 
 
 
 
TABLE 472
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY COMPONENT
 
 
 
 
 
 
TABLE 473
PATIENT ENGAGEMENT SOLUTIONS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 474
PATIENT ENGAGEMENT SOLUTIONS MARKET: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 475
PATIENT ENGAGEMENT SOLUTIONS MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 476
PATIENT ENGAGEMENT SOLUTIONS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 477
MCKESSON CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 478
MCKESSON CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 479
MCKESSON CORPORATION: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 480
ORACLE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 481
ORACLE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 482
ORACLE: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 483
ORACLE: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 484
MICROSOFT (NUANCE COMMUNICATIONS, INC.): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 485
MICROSOFT (NUANCE COMMUNICATIONS, INC.): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 486
MICROSOFT (NUANCE COMMUNICATIONS, INC.): PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 487
MICROSOFT (NUANCE COMMUNICATIONS, INC.): DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 488
TRUBRIDGE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 489
TRUBRIDGE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 490
TRUBRIDGE: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 491
HEALTH CATALYST: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 492
HEALTH CATALYST: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 493
HEALTH CATALYST: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 494
VERADIGM LLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 495
VERADIGM LLC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 496
VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 497
VERADIGM LLC: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 498
ATHENAHEALTH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 499
ATHENAHEALTH: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 500
ATHENAHEALTH: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 501
ATHENAHEALTH: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 502
ATHENAHEALTH: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 503
GETWELLNETWORK, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 504
GETWELLNETWORK, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 505
GETWELLNETWORK, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 506
GETWELLNETWORK, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 507
LINCATA, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 508
LINCATA, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 509
COGNIZANT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 510
COGNIZANT: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 511
COGNIZANT: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 512
ONEVIEW HEALTHCARE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 513
ONEVIEW HEALTHCARE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 514
ONEVIEW HEALTHCARE: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 515
ONEVIEW HEALTHCARE: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 516
ONEVIEW HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 517
ADVANCEDMD, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 518
ADVANCEDMD, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 519
ADVANCEDMD, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 520
ADVANCEDMD, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 521
EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 522
EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 523
EPIC SYSTEMS CORPORATION: PRODUCT ENHANCEMENT, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 524
EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 525
HARRIS HEALTHCARE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 526
HARRIS HEALTHCARE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 527
HARRIS HEALTHCARE: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 528
MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 529
MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 530
MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 531
MEDICAL INFORMATION TECHNOLOGY, INC.: OTHER DEVELOPMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 532
TEBRA TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 533
TEBRA TECHNOLOGIES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 534
TEBRA TECHNOLOGIES, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 535
TEBRA TECHNOLOGIES, INC.: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 536
TELEVOX: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 537
TELEVOX: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 538
TELEVOX: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 539
TELEVOX: DEALS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 540
SOLUTIONREACH, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 541
SOLUTIONREACH, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 542
SOLUTIONREACH, INC.: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022–FEBRUARY 2026
 
 
 
 
 
 
TABLE 543
EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 544
EXPERIAN INFORMATION SOLUTIONS, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 545
ECLINICALWORKS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 546
ECLINICALWORKS: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 547
WELLSTACK: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 548
RELATIENT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 549
LUMA HEALTH INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 550
CIPHERHEALTH INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 551
YOSI HEALTH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 552
PATIENT ENGAGEMENT SOLUTIONS MARKET: STUDY ASSUMPTIONS
 
 
 
 
 
 
TABLE 553
PATIENT ENGAGEMENT SOLUTIONS MARKET: RISK ANALYSIS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
PATIENT ENGAGEMENT SOLUTIONS MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
PATIENT ENGAGEMENT SOLUTIONS MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
PATIENT ENGAGEMENT SOLUTIONS MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, 2024–2031 (USD BILLION)
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022–2026
 
 
 
 
 
 
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
FIGURE 7
HIGH-GROWTH SEGMENTS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PATIENT ENGAGEMENT SOLUTIONS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
GROWING ADOPTION OF TELEHEALTH AND REMOTE CARE TO DRIVE MARKET
 
 
 
 
 
 
FIGURE 10
ON-PREMISES AND US TO ACCOUNT FOR LARGEST NORTH AMERICAN PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE IN 2026
 
 
 
 
 
 
FIGURE 11
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 12
PATIENT ENGAGEMENT SOLUTIONS MARKET DYNAMICS
 
 
 
 
 
 
FIGURE 13
PORTER’S FIVE FORCES ANALYSIS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
FIGURE 14
PATIENT ENGAGEMENT SOLUTIONS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 15
PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 16
TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
FIGURE 17
FUNDING (USD MILLION) AND NUMBER OF DEALS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
FIGURE 18
PATENT PUBLICATION TRENDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2015–2025
 
 
 
 
 
 
FIGURE 19
JURISDICTION AND TOP APPLICANT ANALYSIS FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
FIGURE 20
TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT ENGAGEMENT SOLUTIONS MARKET (JANUARY 2015 TO DECEMBER 2025)
 
 
 
 
 
 
FIGURE 21
MARKET POTENTIAL OF AI/GEN AI ON PATIENT ENGAGEMENT SOLUTIONS ACROSS INDUSTRIES
 
 
 
 
 
 
FIGURE 22
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
 
 
 
 
 
 
FIGURE 23
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
 
 
 
 
 
 
FIGURE 24
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
FIGURE 25
NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 26
ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 27
REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2020–2024 (USD MILLION)
 
 
 
 
 
 
FIGURE 28
MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2024)
 
 
 
 
 
 
FIGURE 29
PATIENT ENGAGEMENT SOLUTIONS MARKET: BRAND COMPARITIVE ANALYSIS
 
 
 
 
 
 
FIGURE 30
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 31
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 32
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (2025)
 
 
 
 
 
 
FIGURE 33
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 34
PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 35
MCKESSON CORPORATION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 36
ORACLE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 37
MICROSOFT (NUANCE COMMUNICATIONS, INC.): COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 38
TRUBRIDGE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 39
HEALTH CATALYST: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 40
VERADIGM LLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 41
COGNIZANT: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 42
ONEVIEW HEALTHCARE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 43
EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 44
PATIENT ENGAGEMENT SOLUTIONS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 45
PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
 
FIGURE 46
PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 47
PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 48
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 49
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
 
 
FIGURE 50
PATIENT ENGAGEMENT SOLUTIONS MARKET: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 51
PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 52
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF PATIENT ENGAGEMENT SOLUTIONS MARKET
 
 
 
 
 
 
FIGURE 53
PATIENT ENGAGEMENT SOLUTIONS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
 
 
 
 
 
 
FIGURE 54
PATIENT ENGAGEMENT SOLUTIONS MARKET: DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

Methodology

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Patient Engagement Solutions market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the patient engagement solutions market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as WHO, ATA, AHA and AAHM. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global patient engagement solutions market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global patient engagement solutions market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, Payers- Private and Public Insurance Bodies, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

A breakdown of primary respondents is provided below:

Patient Engagement Solutions Market 
 Size, and Share

Notes: The tier of companies is defined based on their total revenues. As of 2025, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

C-level executives include CEOs, COOs, CTOs, and VPs.
Other primaries include sales managers, marketing managers, and product managers.

COMPANY NAME

DESIGNATION

Oracle Corporation

Product Manager

Veradigm

Director

Merative

Senior Product Manager

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the global patient engagement solutions market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The revenue generated from the sale of patient engagement solutions products by leading players has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Market Size Estimation- Top-Down Approach and Bottom-Up Approach

Patient Engagement Solutions Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the patient engagement solutions market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the patient engagement solutions market.

Market Definition

The patient engagement solutions market includes digital platforms and tools that enable patients to actively participate in their healthcare through features such as patient portals, secure messaging, appointment scheduling, telehealth, remote monitoring, and others. These solutions integrate with healthcare IT systems like EHRs to improve patient-provider communication, enhance care coordination, and support better health outcomes.

Key Stakeholders

  • Healthcare institutes/providers (hospitals, medical groups, physician practices, diagnostic centers, pharmacies, ambulatory centers, and outpatient clinics)
  • Healthcare insurance companies/payers
  • Healthcare IT service providers
  • Venture capitalists
  • Government bodies
  • Corporate healthcare entities
  • Accountable care organizations

Report Objectives

  • To define, describe, and forecast the global patient engagement solutions market based on component, delivery mode, application, therapeutic area, functionality, end user, and region
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall patient engagement solutions market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically analyze the market structure and profile the key players of the patient engagement solutions market and comprehensively analyze their core competencies
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East & Africa
  • To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the patient engagement solutions market during the forecast period.

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company information

  • Detailed analysis and profiling of additional market players (up to 20)

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Patient Engagement Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Patient Engagement Solutions Market

avtar

Ethan

Oct, 2022

What will be the value for the global Patient Engagement Solutions Market in 2030?.

avtar

Benjamin

Oct, 2022

Which of the geographical segment holds the major share of the Patient Engagement Solutions Market?.

avtar

Michael

Jun, 2026

After reviewing the Patient Engagement Solutions Market report, I gained a clearer understanding of how digital care coordination and remote monitoring platforms are influencing long-term patient retention strategies across healthcare systems..

avtar

William

Jun, 2026

I found the breakdown of patient engagement technologies and end-user adoption particularly useful for evaluating where healthcare providers are prioritizing investments in personalized communication and chronic care management..

avtar

David

Jun, 2026

The report helped me assess the competitive landscape of the Patient Engagement Solutions Market from an operational perspective, especially the growing role of mobile health applications and AI-enabled patient interaction tools..

DMCA.com Protection Status
popup img